Literature DB >> 34290074

Rethinking Cancer Clinical Trial Conduct Induced by COVID-19: An Academic Center, Industry, Government, and Regulatory Agency Perspective.

Keith T Flaherty1, James H Doroshow2, Susan Galbraith3, Antoni Ribas4, Paul G Kluetz5, Richard Pazdur5, Marc R Theoret5.   

Abstract

The COVID-19 pandemic brought about major changes in cancer clinical trials. In its aftermath, the community has an opportunity to incorporate some of these changes as part of the future of trial conduct to make it more patient centered. ©2021 American Association for Cancer Research.

Entities:  

Mesh：

Year:  2021        PMID： 34290074      PMCID： PMC8340848          DOI： 10.1158/2159-8290.CD-21-0850

Source DB:  PubMed          Journal:  Cancer Discov        ISSN： 2159-8274            Impact factor:   39.397


  5 in total

1.  What Keeps Patients Out of Clinical Trials?

Authors:  Lori M Minasian; Joseph M Unger
Journal:  JCO Oncol Pract       Date:  2020-02-19

2.  Potential impact of the COVID-19 pandemic on financial toxicity in cancer survivors.

Authors:  Khalil Baddour; Lauren D Kudrick; Aakriti Neopaney; Lindsay M Sabik; Shyamal D Peddada; Marci L Nilsen; Jonas T Johnson; Robert L Ferris; Leila J Mady
Journal:  Head Neck       Date:  2020-04-28       Impact factor: 3.147

3.  Variation in the estimated costs of pivotal clinical benefit trials supporting the US approval of new therapeutic agents, 2015-2017: a cross-sectional study.

Authors:  Thomas J Moore; James Heyward; Gerard Anderson; G Caleb Alexander
Journal:  BMJ Open       Date:  2020-06-11       Impact factor: 2.692

4.  "When Offered to Participate": A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical Trials.

Authors:  Joseph M Unger; Dawn L Hershman; Cathee Till; Lori M Minasian; Raymond U Osarogiagbon; Mark E Fleury; Riha Vaidya
Journal:  J Natl Cancer Inst       Date:  2021-03-01       Impact factor: 13.506
  5 in total
  8 in total

1.  Use of Communication Technology to Improve Clinical Trial Participation in Adolescents and Young Adults With Cancer: Consensus Statement From the Children's Oncology Group Adolescent and Young Adult Responsible Investigator Network.

Authors:  Viswatej Avutu; Varun Monga; Nupur Mittal; Aniket Saha; Jeffrey R Andolina; Danielle E Bell; Douglas B Fair; Jamie E Flerlage; Jamie N Frediani; Jessica L Heath; Justine M Kahn; Jennifer L Reichek; Leanne Super; Michael A Terao; David R Freyer; Michael E Roth
Journal:  JCO Oncol Pract       Date:  2021-12-14

2.  Impact of COVID-19 on Hematology-Oncology Fellowship Programs: A Quantitative and Qualitative Survey Assessment of Fellowship Program Directors.

Authors:  Ana I Velazquez; Urshila Durani; Lachelle D Weeks; Ajay Major; Robby Reynolds; Ashok Kumbamu; Devika G Das; Martina C Murphy; Elizabeth Henry; Alfred I Lee; Ariela L Marshall
Journal:  JCO Oncol Pract       Date:  2022-01-11

3.  Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition.

Authors:  Bob T Li; Bobby Daly; Mary Gospodarowicz; Monica M Bertagnolli; Otis W Brawley; Bruce A Chabner; Lola Fashoyin-Aje; R Angelo de Claro; Elizabeth Franklin; Jennifer Mills; Jeff Legos; Karen Kaucic; Mark Li; Lydia The; Tina Hou; Ting-Hui Wu; Bjorn Albrecht; Yi Shao; Justin Finnegan; Jing Qian; Javad Shahidi; Eduard Gasal; Craig Tendler; Geoffrey Kim; James Yan; Phuong Khanh Morrow; Charles S Fuchs; Lianshan Zhang; Robert LaCaze; Stefan Oelrich; Martin J Murphy; Richard Pazdur; Kevin Rudd; Yi-Long Wu
Journal:  Nat Med       Date:  2022-04       Impact factor: 87.241

Review 4.  Oncology During the COVID-19 Pandemic: a Lockdown Perspective.

Authors:  Danielle Boniface; Gonzalo Tapia-Rico
Journal:  Curr Oncol Rep       Date:  2022-05-27       Impact factor: 5.945

5.  Role of decentralized clinical trials in cancer drug development: Results from a survey of oncologists and patients.

Authors:  Begoña de Las Heras; Adam Daehnke; Kamal S Saini; Melissa Harris; Kenneth Morrison; Ariel Aguilo; Isagani Chico; Laura Vidal; Robin Marcus
Journal:  Digit Health       Date:  2022-05-25

6.  Impact of the Coronavirus Disease 2019 Pandemic on Global Lung Cancer Clinical Trials: Why It Matters to People With Lung Cancer.

Authors:  Upal Basu Roy; Anne-Marie Baird; Andrew Ciupek; Jesme Fox; Eugene Manley; Kim Norris Xx; Giorgio V Scagliotti; Heather A Wakelee; Tetsuya Mitsudomi; Russell C Clark; Renee Arndt; Fred R Hirsch; Paul A Bunn; Matthew P Smeltzer
Journal:  JTO Clin Res Rep       Date:  2021-12-23

7.  International Association for the Study of Lung Cancer Study of the Impact of Coronavirus Disease 2019 on International Lung Cancer Clinical Trials.

Authors:  Matthew P Smeltzer; Giorgio V Scagliotti; Heather A Wakelee; Tetsuya Mitsudomi; Upal Basu Roy; Russell C Clark; Renee Arndt; Clayton D Pruett; Karen L Kelly; Peter Ujhazy; Melissa L Johnson; Yesim Eralp; Carlos H Barrios; Fabrice Barlesi; Fred R Hirsch; Paul A Bunn
Journal:  J Thorac Oncol       Date:  2022-02-17       Impact factor: 20.121

Review 8.  Clinical Evidence Generation During a Pandemic: Lessons Learned for Sustaining Progress.

Authors:  Donna R Rivera; Paul G Kluetz; Kald Abdallah; Sundeep Agrawal; Derek C Angus; Robert M Califf; Elizabeth Garrett-Mayer; Randall Hyer; Douglas R Lowy; Samir N Khleif
Journal:  Cancer J       Date:  2022 Mar-Apr 01       Impact factor: 2.074
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.